JPS59501714A - 広いスペクトルのインフルエンザ抗血清 - Google Patents

広いスペクトルのインフルエンザ抗血清

Info

Publication number
JPS59501714A
JPS59501714A JP58502916A JP50291683A JPS59501714A JP S59501714 A JPS59501714 A JP S59501714A JP 58502916 A JP58502916 A JP 58502916A JP 50291683 A JP50291683 A JP 50291683A JP S59501714 A JPS59501714 A JP S59501714A
Authority
JP
Japan
Prior art keywords
peptide
amino acid
acid residue
sequence
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58502916A
Other languages
English (en)
Japanese (ja)
Inventor
グリ−ン・ニコラ
アレキサンダ−・スチ−ブン
Original Assignee
スクリツプス　クリニツク　アンド　リサ−チ　フアウンデ−シヨン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スクリツプス　クリニツク　アンド　リサ−チ　フアウンデ−シヨン filed Critical スクリツプス　クリニツク　アンド　リサ−チ　フアウンデ−シヨン
Publication of JPS59501714A publication Critical patent/JPS59501714A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58502916A 1982-08-23 1983-08-23 広いスペクトルのインフルエンザ抗血清 Pending JPS59501714A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23
US410455DEEDK 1982-08-23

Publications (1)

Publication Number Publication Date
JPS59501714A true JPS59501714A (ja) 1984-10-11

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58502916A Pending JPS59501714A (ja) 1982-08-23 1983-08-23 広いスペクトルのインフルエンザ抗血清

Country Status (16)

Country Link
EP (1) EP0116629A4 (oth)
JP (1) JPS59501714A (oth)
KR (1) KR840006198A (oth)
AU (1) AU570929B2 (oth)
DK (1) DK203684D0 (oth)
ES (1) ES8505819A1 (oth)
FI (1) FI841583L (oth)
GR (1) GR78931B (oth)
IL (1) IL69556A (oth)
IT (1) IT1168636B (oth)
NO (1) NO161002C (oth)
NZ (2) NZ205341A (oth)
PH (1) PH18872A (oth)
PT (1) PT77230B (oth)
WO (1) WO1984000687A1 (oth)
ZA (1) ZA836080B (oth)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684146A (en) * 1994-03-30 1997-11-04 Takara Shuzo Co., Ltd. DNA coding for variable region to human influenza A type virus
JP2009537147A (ja) * 2006-05-15 2009-10-29 シー レーン バイオテクノロジーズ， エルエルシー インフルエンザウイルスに対する中和抗体
JP2010502207A (ja) * 2006-09-07 2010-01-28 クルセル ホランド ベー ヴェー インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
WO2010073647A1 (ja) 2008-12-25 2010-07-01 国立大学法人大阪大学 抗ヒトインフルエンザウイルス・ヒト型抗体

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
WO1990008161A1 (en) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
EP0621339B1 (en) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Immunogenic human influenza A virus haemagglutinin polypeptides
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
ITTO20070066A1 (it) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc Anticorpi monoclonali anti-idiotipo mimotopi dell'antigene gp 120 di hiv
BRPI0809435A2 (pt) 2007-03-27 2014-09-09 Sea Lane Biotechnologies, Llc Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
WO2009121004A2 (en) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
ITTO20080398A1 (it) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
ITTO20080964A1 (it) 2008-12-22 2010-06-23 Natimab Therapeutics S R L Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv
EP3009145A1 (en) 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
CN102482345A (zh) 2009-05-13 2012-05-30 航道生物技术有限责任公司 针对流感病毒的中和分子
AU2010254136B2 (en) 2009-05-26 2016-09-29 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
IT1395961B1 (it) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
CA2790380A1 (en) * 2010-02-18 2011-08-25 Mount Sinai School Of Medicine Vaccines for use in the prophylaxis and treatment of influenza virus disease
EP3248615A1 (en) 2010-03-30 2017-11-29 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
WO2013016714A1 (en) 2011-07-28 2013-01-31 Sea Lane Biotechnologies Sur-binding proteins against erbb3
IN2014CN02114A (oth) 2011-09-20 2015-05-29 Sinai School Medicine
EP3446707A1 (en) 2011-12-22 2019-02-27 i2 Pharmaceuticals, Inc. Surrogate binding proteins
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
EA201591164A1 (ru) 2012-12-18 2015-11-30 Икан Скул Оф Медсин Эт Маунт Синай Вакцины против вируса гриппа и их применение
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
EP3247389A4 (en) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai INFLUENZAVIRUSSCHUTZIMPFPLÄNE
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN109195629A (zh) 2016-02-24 2019-01-11 威特拉公司 流行性感冒抗体分子制剂
CA3023143A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
EP3810634A4 (en) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
CN113924147A (zh) 2019-03-25 2022-01-11 威特拉公司 用于治疗和预防流感的组合物和方法
EP3959216A4 (en) 2019-04-24 2023-01-11 Icahn School of Medicine at Mount Sinai ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684146A (en) * 1994-03-30 1997-11-04 Takara Shuzo Co., Ltd. DNA coding for variable region to human influenza A type virus
JP2009537147A (ja) * 2006-05-15 2009-10-29 シー レーン バイオテクノロジーズ， エルエルシー インフルエンザウイルスに対する中和抗体
JP2010502207A (ja) * 2006-09-07 2010-01-28 クルセル ホランド ベー ヴェー インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
WO2010073647A1 (ja) 2008-12-25 2010-07-01 国立大学法人大阪大学 抗ヒトインフルエンザウイルス・ヒト型抗体

Also Published As

Publication number Publication date
ES525088A0 (es) 1985-06-16
DK203684A (da) 1984-04-18
EP0116629A4 (en) 1987-06-29
IL69556A0 (en) 1983-11-30
IT8348868A1 (it) 1985-02-22
PT77230A (en) 1983-09-01
NZ220612A (en) 1988-07-28
PT77230B (en) 1986-02-04
WO1984000687A1 (en) 1984-03-01
AU1947183A (en) 1984-03-07
KR840006198A (ko) 1984-11-22
AU570929B2 (en) 1988-03-31
ZA836080B (en) 1984-04-25
IT1168636B (it) 1987-05-20
NO161002C (no) 1989-06-21
EP0116629A1 (en) 1984-08-29
IL69556A (en) 1988-05-31
PH18872A (en) 1985-10-21
FI841583A0 (fi) 1984-04-19
NZ205341A (en) 1988-07-28
IT8348868A0 (it) 1983-08-22
NO161002B (no) 1989-03-13
NO841540L (no) 1984-04-17
GR78931B (oth) 1984-10-02
DK203684D0 (da) 1984-04-18
FI841583A7 (fi) 1984-04-19
ES8505819A1 (es) 1985-06-16
FI841583L (fi) 1984-04-19

Similar Documents

Publication Publication Date Title
JPS59501714A (ja) 広いスペクトルのインフルエンザ抗血清
US4625015A (en) Broad spectrum influenza antisera
US20090053257A1 (en) Replikin peptides and uses thereof
JPH04502760A (ja) エイズの診断，予防および治療に有効な新規ｈｉｖ蛋白質およびペプチド
JP2001502315A (ja) ウイルス感染を処置するための組成物および方法
ES2281900T3 (es) Peptidos sinteticos y vacunas que los contienen.
JP2616915B2 (ja) 中和糖タンパク質のペプチド
WO2013059426A1 (en) Human endogenous retrovirus peptides, antibodies to the peptides, and methods of use thereof
Mosa et al. A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice
RU2181379C2 (ru) Пептид (варианты) и способ его производства, фармацевтическое средство, антитело и способ его производства
US7435721B2 (en) Transport peptides such as C-terminal Erns peptide and analogues thereof
JPH03128399A (ja) エイズ用複合免疫原
JPH07505878A (ja) Ｈｉｖエンベロープ糖タンパク質から誘導された合成ポリペプチド
US9534020B2 (en) Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide
JPS59501866A (ja) 腸内ウイルスに対するワクチン接種に有用なポリペプチド
US20230192813A1 (en) Antibody that binds specifically to the sars cov 2 spike protein, and methods for its manufacture
AU733234B2 (en) Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders
EP3892298A1 (en) Epitopes having sequence homology to coronavirus spike protein subunit and uses thereof
BR112020001586A2 (pt) vacina contra malária
Bukawa et al. Antibody Responses Raised against a Conformational V3 Loop Peptide of HIV‐1
Sundaram et al. Structural and immunogenicity analysis of chimeric B‐cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV‐1
US11793873B2 (en) Bivalent dengue/hepatitis B vaccines
US20110262894A1 (en) Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and methods of diagnosis
CN114053400B (zh) 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法
EP0370090A1 (en) Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens.